搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Clostridium perfringens Dihydrodipicolinate reductase (dapB) CSB-YP608236CAAP
CSB-EP608236CAAP
CSB-BP608236CAAP
CSB-MP608236CAAP
CSB-EP608236CAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Elongation factor P (efp) CSB-YP608237CAAP
CSB-EP608237CAAP
CSB-BP608237CAAP
CSB-MP608237CAAP
CSB-EP608237CAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Exodeoxyribonuclease 7 large subunit (xseA) CSB-YP608238CAAP
CSB-EP608238CAAP
CSB-BP608238CAAP
CSB-MP608238CAAP
CSB-EP608238CAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Segregation and condensation protein B (scpB) CSB-YP608239CAAP
CSB-EP608239CAAP
CSB-BP608239CAAP
CSB-MP608239CAAP
CSB-EP608239CAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Transcriptional repressor NrdR (nrdR) CSB-YP608240CAAP
CSB-EP608240CAAP
CSB-BP608240CAAP
CSB-MP608240CAAP
CSB-EP608240CAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens 50S ribosomal protein L28 (rpmB) CSB-YP608241CAAP
CSB-EP608241CAAP
CSB-BP608241CAAP
CSB-MP608241CAAP
CSB-EP608241CAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Acyl carrier protein (acpP) CSB-YP608242CAAP
CSB-EP608242CAAP
CSB-BP608242CAAP
CSB-MP608242CAAP
CSB-EP608242CAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Ribonuclease HII (rnhB) CSB-YP608243CAAP
CSB-EP608243CAAP
CSB-BP608243CAAP
CSB-MP608243CAAP
CSB-EP608243CAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Ribosome-recycling factor (frr) CSB-YP608244CAAP
CSB-EP608244CAAP
CSB-BP608244CAAP
CSB-MP608244CAAP
CSB-EP608244CAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Ribosomal protein S12 methylthiotransferase RimO (rimO) CSB-YP608245CAAP
CSB-EP608245CAAP
CSB-BP608245CAAP
CSB-MP608245CAAP
CSB-EP608245CAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Thiazole synthase (thiG) CSB-YP608246CAAP
CSB-EP608246CAAP
CSB-BP608246CAAP
CSB-MP608246CAAP
CSB-EP608246CAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Porphobilinogen deaminase (hemC) CSB-YP608247CAAP
CSB-EP608247CAAP
CSB-BP608247CAAP
CSB-MP608247CAAP
CSB-EP608247CAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens D-alanine--D-alanine ligase (ddl) CSB-YP608248CAAP
CSB-EP608248CAAP
CSB-BP608248CAAP
CSB-MP608248CAAP
CSB-EP608248CAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Undecaprenyl-diphosphatase (uppP), partial CSB-YP608249CAAP
CSB-EP608249CAAP
CSB-BP608249CAAP
CSB-MP608249CAAP
CSB-EP608249CAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Citrate lyase acyl carrier protein (citD) CSB-YP608250CAAP
CSB-EP608250CAAP
CSB-BP608250CAAP
CSB-MP608250CAAP
CSB-EP608250CAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta (accD) CSB-YP608251CAAP
CSB-EP608251CAAP
CSB-BP608251CAAP
CSB-MP608251CAAP
CSB-EP608251CAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Cobyric acid synthase (cobQ) CSB-YP608252CAAP
CSB-EP608252CAAP
CSB-BP608252CAAP
CSB-MP608252CAAP
CSB-EP608252CAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens 3-phosphoshikimate 1-carboxyvinyltransferase (aroA) CSB-YP608253CAAP
CSB-EP608253CAAP
CSB-BP608253CAAP
CSB-MP608253CAAP
CSB-EP608253CAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Phosphate import ATP-binding protein PstB (pstB) CSB-YP608254CAAP
CSB-EP608254CAAP
CSB-BP608254CAAP
CSB-MP608254CAAP
CSB-EP608254CAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Quinolinate synthase A (nadA) CSB-YP608255CAAP
CSB-EP608255CAAP
CSB-BP608255CAAP
CSB-MP608255CAAP
CSB-EP608255CAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>